Overall, most physicians indicated preferring an anti-IgE for allergic asthma (59% of physicians), an anti-IL5 for eosinophilic asthma (87%), and an anti-TSLP for Type 2 Low asthma (68%) (Fig. 4). Here, IL5 is linked to allergic asthma.